VistaGen Therapeutics Inc... (VTGN)
NASDAQ: VTGN
· Real-Time Price · USD
3.31
0.35 (12.01%)
At close: Aug 15, 2025, 3:59 PM
3.32
0.27%
After-hours: Aug 15, 2025, 07:58 PM EDT
VistaGen Therapeutics Income Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Revenue | 646K | 486K | 698.3K | 875.7K | 970.7K | 1.06M | 1.04M | 810.2K | -360.3K | -227.2K | -363.9K | -185.6K | 1.06M | 1.11M | 1.51M | 1.47M | 1.44M | 1.09M | 647.6K | 334K | n/a |
Cost of Revenue | 648K | 630K | 615.5K | 597.7K | 581K | 430K | 283.5K | 140.3K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 477K | 486K | 698.3K | 875.7K | 970.7K | 1.06M | 1.04M | 810.2K | -360.3K | -227.2K | -363.9K | -185.6K | 1.06M | 1.11M | 1.51M | 1.47M | 1.44M | 1.09M | 647.6K | 334K | n/a |
Operating Income | -59.65M | -55.97M | -52.84M | -45.6M | -38.15M | -33.02M | -33.9M | -35.78M | -46.49M | -59.27M | -63.72M | -64.5M | -59.81M | -47.78M | -37.3M | -32.06M | -22.56M | -17.93M | -14.98M | -15.64M | -17.7M |
Interest Income | 3.87M | 4.56M | 5.23M | 5.73M | 4.65M | 3.36M | 1.84M | 321.5K | 144.6K | 47.4K | 37.4K | 31.1K | 21K | 20K | 24K | 23K | 20K | 15K | 8K | 8K | 25K |
Pretax Income | -55.77M | -51.41M | -47.3M | -39.56M | -33.19M | -29.36M | -32.06M | -35.48M | -46.37M | -59.24M | -63.7M | -64.48M | -59.79M | -47.76M | -37.28M | -32.05M | -22.55M | -17.93M | -14.99M | -15.65M | -17.69M |
Net Income | -55.78M | -51.42M | -47.3M | -39.57M | -33.19M | -29.36M | -32.07M | -35.48M | -46.37M | -59.25M | -63.71M | -64.48M | -59.79M | -47.76M | -37.28M | -32.05M | -22.55M | -17.93M | -14.99M | -15.65M | -17.69M |
Selling & General & Admin | 16.89M | 17.08M | 16.93M | 16.64M | 15.65M | 14.06M | 13.1M | 12.43M | 12.93M | 14.74M | 16.55M | 16.57M | 16.09M | 13.71M | 10.52M | 9.52M | 7.57M | 6.55M | 6.2M | 6.21M | 6.08M |
Research & Development | 43.41M | 39.38M | 36.6M | 29.84M | 23.47M | 20.02M | 21.92M | 24.24M | 33.28M | 44.38M | 46.81M | 47.74M | 44.78M | 34.94M | 28.06M | 23.78M | 16.2M | 12.48M | 9.43M | 8.94M | 10.79M |
Other Expenses | -169K | n/a | -300 | -500 | -500 | -500 | -77.8K | -77.5K | -77.2K | -77.4K | 400.00 | 400.00 | 300.00 | 232.6K | 232.4K | 232.1K | 231.4K | -1.1K | -1.3K | 826.2K | 826.8K |
Operating Expenses | 60.12M | 56.46M | 53.54M | 46.48M | 39.12M | 34.08M | 34.94M | 36.59M | 46.13M | 59.04M | 63.36M | 64.31M | 60.87M | 48.89M | 38.82M | 33.53M | 24M | 19.02M | 15.63M | 15.98M | 17.7M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 6K | 9K | 15K | 24K | 22K | 19K | 13K | 4K | n/a | 1K | 4K | 10K | 13K | 17K | 16K | 14K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 84K | 84K | 84K | 1.39M | 2.67M | 3.52M | 4M | 2.8M | 1.42M | 577K | 102K | n/a | n/a | n/a | n/a |
Cost & Expenses | 60.29M | 56.46M | 53.54M | 46.48M | 39.12M | 34.08M | 34.94M | 36.59M | 46.13M | 59.04M | 63.36M | 64.31M | 60.87M | 48.89M | 38.82M | 33.53M | 24M | 19.02M | 15.63M | 15.98M | 17.7M |
Income Tax Expense | 7K | 7K | 8.5K | 8.5K | 1.5K | 4.5K | 3.4K | 3.4K | 3.4K | 5.9K | 5.5K | 5.5K | 5.5K | 3.4K | 3.4K | 3.4K | 3.6K | 2.6K | 2.6K | 2.8K | 2.6K |
Shares Outstanding (Basic) | 31.93M | 30.71M | 30.71M | 30.63M | 30.6M | 27.03M | 14.7M | 10.04M | 7.38M | 7.16M | 6.89M | 6.89M | 6.89M | 6.88M | 6.74M | 6.44M | 6.33M | 4.83M | 2.7M | 2.24M | 1.71M |
Shares Outstanding (Diluted) | 31.93M | 30.71M | 30.71M | 30.63M | 30.6M | 27.03M | 14.7M | 10.04M | 7.38M | 7.16M | 6.89M | 6.89M | 6.89M | 6.88M | 6.74M | 6.44M | 6.33M | 4.83M | 2.7M | 2.24M | 1.71M |
EPS (Basic) | -1.79 | -1.67 | -1.58 | -1.55 | -1.79 | -2.38 | -3.74 | -4.73 | -6.61 | -8.54 | -9.26 | -9.4 | -8.85 | -7.2 | -6.06 | -6.46 | -5.94 | -6.55 | -7.34 | -9.52 | -11.81 |
EPS (Diluted) | -1.79 | -1.67 | -1.58 | -1.55 | -1.79 | -2.38 | -3.74 | -4.73 | -6.61 | -8.54 | -9.26 | -9.4 | -8.85 | -7.2 | -6.06 | -6.46 | -5.94 | -6.55 | -7.34 | -9.52 | -11.81 |
EBITDA | -58.28M | -55.34M | -52.22M | -45M | -37.57M | -32.45M | -33.33M | -35.22M | -45.94M | -58.71M | -63.18M | -63.77M | -59.07M | -47.05M | -36.66M | -31.62M | -22.05M | -17.53M | -14.6M | -15.36M | -17.57M |
EBIT | -58.94M | -55.97M | -52.84M | -45.6M | -38.15M | -33.02M | -33.89M | -35.77M | -46.48M | -59.25M | -63.71M | -64.48M | -59.78M | -47.76M | -37.28M | -32.04M | -22.54M | -17.92M | -14.97M | -15.63M | -17.67M |
Depreciation & Amortization | 653K | 635K | 615.5K | 598K | 580K | 568K | 558.6K | 547.3K | 540.9K | 531.2K | 527.5K | 711.3K | 711.6K | 711.1K | 618K | 419.2K | 488.5K | 385.1K | 370.3K | 278.6K | 102.3K |